Cardinal Health, Inc.

$19.00

SKU: CAH Category:

Description

Cardinal Health delivered a solid result and managed an all-around beat in the last quarter, exceeding expectations and achieving significant milestones. The reported EPS of $1.73 marked a remarkable start, driven by the outstanding performance in the pharmaceutical and medical sectors. The success is primarily attributed to the strength of the pharma business, progress in medical turnaround efforts, and a disciplined approach to capital allocation. Consolidated enterprise results showcased a 10% increase in total revenue to $54.8 billion, primarily fueled by the Pharma segment. The gross margin also saw a commendable 10% rise to $1.8 billion, propelled by both the medical and pharmaceutical segments. The Pharma segment reported a noteworthy 11% increase in revenue to $51 billion, with brand and specialty pharmaceutical sales driving the growth. Despite flat revenue of $3.8 billion in the Medical segment, the company exceeded expectations in Q1.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!